Abstract:The p42/44 mitogen-activated protein (MAP)-kinase cascade is a well-established signal transduction pathway that is initiated at the cell surface and terminates within the nucleus. More specifically, receptor tyrosine kinases can indirectly activate Raf, which in turn leads to activation of MEK and ERK and ultimately phosphorylation of Elk, a nuclear transcription factor. Recent reports have suggested that some members of p42/44 MAP kinase cascade can be sequestered within plasmalemmal caveolae in vivo. For example, morphological studies have directly shown that ERK-1/2 is concentrated in plasma membrane caveolae in vivo using immunoelectron microscopy. In addition, constitutive activation of the p42/44 MAP kinase cascade is sufficient to reversibly down-regulate caveolin-1 mRNA and protein expression. However, the functional relationship between the p42/44 MAP kinase cascade and caveolins remains unknown. Here, we examine the in vivo role of caveolins in regulating signaling along the MAP kinase cascade. We find that co-expression with caveolin 1 dramatically inhibits signaling from EGF-R, Raf, MEK-1 and ERK-2 to the nucleus. Using a variety of caveolin-1 deletion mutants, we mapped this in vivo inhibitory activity to caveolin-1 residues 32-95. Peptides derived from this region of caveolin 1 also inhibit the in vitro kinase activity of purified MEK-1 and ERK-2. Thus, we show here that caveolin-1 expression can inhibit signal transduction from the p42/44 MAP kinase cascade both in vitro and in vivo. Taken together with previous data, our results also suggest that a novel form of reciprocal negative regulation exists between p42/44 MAP kinase activation and caveolin-1 protein expression, i.e. up-regulation of caveolin-1 protein expression down-modulates p42/44 MAP kinase activity (this report) and up-regulation of p42/44 MAP kinase activity down-regulates caveolin-1 mRNA and protein expression.

Epigenetic modifications of caveolae associated proteins in health and disease

Caveolin's Biological Function and Its Effect in Diseases

Caveolae-Associated Molecules, Tumor Stroma, and Cancer Drug Resistance: Current Findings and Future Perspectives

Unraveling the Cave: A Seventy-Year Journey into the Caveolar Network, Cellular Signaling, and Human Disease

Caveolin As a Novel Potential Therapeutic Target in Cardiac and Vascular Diseases: A Mini Review

Molecular regulation and clinical significance of caveolin‐1 methylation in chronic lung diseases

The Role of Caveolae in Endothelial Dysfunction.

Insights in caveolae protein structure arrangements and their local lipid environment

Physiological and pathological roles of caveolins in the central nervous system

Role of Caveolin-1 in Tumor Pathogenesis

Caveolae-caveolin and Associated Signaling Molecules

Lessons from cavin-1 deficiency

Caveolin-1 and Tumors

Down‐regulation of the Cavin Family Proteins in Breast Cancer

Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain

Integrated Bioinformatic Analysis of the Expression and Prognosis of Caveolae-Related Genes in Human Breast Cancer

Caveolin-3 and Arrhythmias: Insights into the Molecular Mechanisms

The critical roles of caveolin-1 in lung diseases

Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials

Caveolin-1 in autophagy: A potential therapeutic target in atherosclerosis

Pathophysiology and Molecular Mechanism of Caveolin Involved in Myocardial Protection Strategies in Ischemic Conditioning.